关注
Priyanka Mohapatra
Priyanka Mohapatra
Senior Research Fellow (PhD), Institute of Life Sciences, Bhubaneswar, India
在 ils.res.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Analysis of Indian SARS-CoV-2 genomes reveals prevalence of D614G mutation in spike protein predicting an increase in interaction with TMPRSS2 and virus infectivity
S Raghav, A Ghosh, J Turuk, S Kumar, A Jha, S Madhulika, ...
Frontiers in Microbiology 11, 594928, 2020
572020
Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation
P Singh, D Singh, P Sa, P Mohapatra, A Khuntia, S K Sahoo
Nanomedicine 16 (14), 1219-1235, 2021
442021
Phytochemical based nanomedicine: a panacea for cancer treatment, present status and future prospective
P Mohapatra, P Singh, D Singh, S Sahoo, SK Sahoo
OpenNano 7, 100055, 2022
262022
Phytonanomedicine: A novel avenue to treat recurrent cancer by targeting cancer stem cells
P Mohapatra, P Singh, SK Sahoo
Drug Discovery Today 25 (8), 1307-1321, 2020
242020
Advancements in clinical translation of flavonoid nanoparticles for cancer treatment
T Sharma, D Singh, A Mahapatra, P Mohapatra, S Sahoo, SK Sahoo
OpenNano 8, 100074, 2022
172022
Nimbolide-encapsulated PLGA nanoparticles induces mesenchymal-to-epithelial transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells
D Singh, P Mohapatra, S Kumar, S Behera, A Dixit, SK Sahoo
Toxicology in Vitro 79, 105293, 2022
152022
Design, synthesis, and in-silico study of chromen-sulfonamide congeners as potent anticancer and antimicrobial agents
M Mahapatra, P Mohapatra, SK Sahoo, AK Bishoyi, RN Padhy, ...
Journal of Molecular Structure 1283, 135190, 2023
102023
In-vitro anticancer evaluation of newly designed and characterized tri/tetra-substituted imidazole congeners-maternal embryonic leucine zipper kinase inhibitors: Molecular …
M Mahapatra, P Mohapatra, K Pakeeraiah, RK Bandaru, I Ahmad, S Mal, ...
International Journal of Biological Macromolecules 249, 126084, 2023
92023
Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of Mycobacterium and Mycoplasma in COVID-19 patients: a potential source of co-infection
P Prasad, S Mahapatra, R Mishra, KC Murmu, S Aggarwal, M Sethi, ...
Molecular Omics 18 (6), 490-505, 2022
92022
Phytochemical-based nanomedicine for targeting tumor microenvironment and inhibiting cancer chemoresistance: recent advances and pharmacological insights
P Sa, P Mohapatra, SS Swain, A Khuntia, SK Sahoo
Molecular Pharmaceutics 20 (11), 5254-5277, 2023
72023
Flavonoids for the treatment of breast cancer, present status and future prospective
S Sahoo, P Mohapatra, SK Sahoo
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2023
72023
PEGylated Nanoparticles as a Versatile Drug Delivery System
P Mohapatra, D Singh, SK Sahoo
Nanoengineering of Biomaterials, 309-341, 2022
62022
Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis
P Mohapatra, S Madhulika, S Behera, P Singh, P Sa, P Prasad, RK Swain, ...
Molecular Therapy-Nucleic Acids 34, 102031, 2023
32023
Biosynthesis of rutin trihydrate loaded silica nanoparticles and investigation of its antioxidant, antidiabetic and cytotoxic potentials
RG Kerry, P Mohapatra, AB Jena, B Panigrahi, KC Pradhan, BR Khatua, ...
Journal of Inorganic and Organometallic Polymers and Materials 32 (6), 2065-2081, 2022
22022
Nanopore 16S rRNA sequencing reveals alterations in nasopharyngeal microbiome and enrichment of Mycobacterium and Mycoplasma in patients with COVID 19
S Mahapatra, R Mishra, P Prasad, KC Murmu, S Aggarwal, M Sethi, ...
medRxiv, 2021.11. 10.21266147, 2021
12021
系统目前无法执行此操作,请稍后再试。
文章 1–15